BMJ Group

Glory days are over. - Recensione dipendente - Department Head presso BMJ Group

2,0

13 nov 2017

Consiglia

Gradimento del CEO

Pronostico commerciale

Vantaggi

A powerful brand in medical publishing and clinical knowledge. Investor in people. Pay scales used to be quite good. New CEO seem to be trying his best.

Svantaggi

Multiple rounds (almost back to back) of restructuring and lay offs, which seems to be a never ending phenomenon past 10 years. Company is now retracting back to what it used to be 15 years ago. A smaller medical publisher. Every September with budget review, some hard working people are made scape goats while executives get grander titles. Company which took pride in impartiality and integrity of the clinical knowledge has gotten rid of almost all externally facing clinically qualified staff. Seriously questionable HR practices.

Risposta di BMJ Group

Thank you for your feedback. It is true that we have had some restructuring which has resulted in some redundancies. We try and control these wherever possible with re-deployment and re-training. Our number of redundancies have always remained sub 5% of staff (at it's peak) and have numbered approximately 3% of staff at other times. We have many ways that recognise loyaly and hard work from our STAR awards and annual awards to recognition every 5 years for service.

Glory days are over. - Recensione dipendente - Department Head presso BMJ Group

Esplora altre recensioni su BMJ Group

Aziende seguite

Ricerche di lavoro